$104.23 1.4%
Price vs. AI Score (Last 150 days)
Data gathered: December 7

Data Bits

Data Bits Value / Change Benchmark
Job Posts 292 -1%
Sentiment 97 0%
Webpage traffic 1,024,000 6.6%
Employee Rating 84 0%
Google Adspend $4,523 -63%
Google Trends 32 0%
Linkedin Employees 66,182 N/A
NPS 42 2.4% N/A
Patents 890 0%
4chan Mentions -100%
Facebook Engagement 1,019 1.8%
Facebook followers 97,041 -0%
Stocktwits Mentions 22 29.4%
Stocktwits Subscribers 21,884 0%
Twitter Followers 224,456 -0%
Youtube Subscribers 3,580 0%
Instagram Followers 52,438 0.1%
News Mentions 6 200%
Reddit Mentions 3 0%
Business outlook 81 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Merck & Company

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, diabetes, and women's health, as well as vaccine products. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products.

Merck & Company
Price $104.23
Target Price Sign up
Market Cap $269B
Dividend Yield 0.0293
Industry Drug Manufacturers

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '2316B6.77B9.19B4.75B6B
Q2 '2315B6.77B8.27B-5.98B-4.86B
Q1 '2314.5B6.36B8.13B2.82B3.87B
Q4 '2213.8B9.49B4.35B3.02B3.54B
Q3 '2215B6.49B8.47B3.25B4.2B

Insider Transactions

Oosthuizen Johannes Jacobus filed to sell 18,191 shares at $102.4.
November 13 '23
DeLuca Richard R. filed to sell 111,764 shares at $105.
November 9 '23
MIZELL STEVEN filed to sell 22,935 shares at $109.
August 15 '23
MIZELL STEVEN filed to sell 27,185 shares at $105.5.
August 4 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.